Publications by authors named "Masato Katagiri"

Claim this Profile
S
Sniff and reverse-sniff nasal respiratory pressures after exacerbation of chronic obstructive pulmonary disease: A single-center prospective study.
Tsuyoshi Ichikawa, Sakurako Tajiri, Masanori Yokoba, Yu Horimizu, Saki Yamaguchi, Masato Katagiri

Respir Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.
Tatsuhiko Wada, Makoto Hibino, Hiromi Aono, Shunsuke Kyoda, Yosuke Iwadate, Masato Katagiri

Front Med (Lausanne)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovery of respiratory muscle strength, physical function, and dyspnoea after lobectomy in lung cancer patients undergoing pulmonary rehabilitation: A retrospective study.
Tsuyoshi Ichikawa, Masanori Yokoba, Yu Horimizu, Saki Yamaguchi, Akiko Kawakami, Masato Katagiri

Eur J Cancer Care (Engl)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical feasibility of remote intermittently scanned continuous glucose monitoring in coronavirus disease 2019 patients with and without diabetes during dexamethasone therapy.
Naoya Shimizu, Akinori Hayashi, Shiori Ito, Agena Suzuki, Rei Fujishima, Masato Katagiri

Endocr J· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Air contamination of therapeutic drug monitoring assay reagents results in falsely high plasma ammonia levels.
Tomoaki Tsukushi, Ryota Shinohara, Yuzuru Adachi, Yoshifumi Kurosaki, Naohito Ishii, Masato Katagiri

Ann Clin Biochem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells.
Yoshifumi Kurosaki, Akemi Imoto, Fumitaka Kawakami, Motoshi Ouchi, Asuka Morita, Masato Katagiri

Mol Cell Biochem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panton-Valentine Leukocidin Induces Cytokine Release and Cytotoxicity Mediated by the C5a Receptor on Rabbit Alveolar Macrophages.
Shinya Harada, Hayato Kawada, Shotaro Maehana, Hidehito Matsui, Makoto Kubo, Masato Katagiri

Jpn J Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer.
Satoshi Igawa, Taihei Ono, Masashi Kasajima, Seiichiro Kusuhara, Sakiko Otani, Masato Katagiri

Invest New Drugs· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between quantitative computed tomography, scintigraphy, and anatomical methods for prediction of postoperative FEV and DLCO: effects of chronic obstructive pulmonary disease status and resected lobes.
Masanori Yokoba, Tsuyoshi Ichikawa, Shinya Harada, Kazu Shiomi, Masashi Mikubo, Masato Katagiri

J Thorac Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
Taihei Ono, Satoshi Igawa, Shintaro Kurahayashi, Yuriko Okuma, Ai Sugimoto, Masato Katagiri

Invest New Drugs· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer.
Satoshi Igawa, Taihei Ono, Masashi Kasajima, Hideaki Manabe, Tomoya Fukui, Masato Katagiri

Cancer Manag Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.
Tomoya Fukui, Shinji Hosotani, Itaru Soda, Takahiro Ozawa, Seiichiro Kusuhara, Masato Katagiri

Thorac Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara, Shinya Harada, Noriko Nishinarita, Masato Katagiri

PLoS One· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017.
Yoshiro Nakahara, Yukio Hosomi, Masahiko Shibuya, Hisashi Mitsufuji, Masato Katagiri

Mol Clin Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study.
Tomoya Fukui, Yuriko Okuma, Yoshiro Nakahara, Sakiko Otani, Satoshi Igawa, Masato Katagiri

Clin Lung Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of genotype on the efficacy of osimertinib in tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study.
Satoshi Igawa, Taihei Ono, Masashi Kasajima, Mikiko Ishihara, Yasuhiro Hiyoshi, Masato Katagiri

Cancer Manag Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non-small cell lung cancer harboring an EGFR mutation: A prospective observational study.
Taihei Ono, Satoshi Igawa, Takahiro Ozawa, Masashi Kasajima, Mikiko Ishihara, Masato Katagiri

Thorac Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Questionnaire survey on patient awareness of invasive rebiopsy in advanced non-small cell lung cancer.
Tomoya Fukui, Mikiko Ishihara, Masashi Kasajima, Yasuhiro Hiyoshi, Yoshiro Nakahara, Masato Katagiri

Thorac Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genioglossus muscle activity during sniff and reverse sniff in healthy men.
Tsuyoshi Ichikawa, Masanori Yokoba, Masahiko Kimura, Manaka Shibuya, Paul A Easton, Masato Katagiri

Exp Physiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease.
Satoshi Igawa, Noriko Nishinarita, Akira Takakura, Takahiro Ozawa, Shinya Harada, Masato Katagiri

Cancer Manag Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative pulmonary function changes according to the resected lobe: a 1-year follow-up study of lobectomized patients.
Masanori Yokoba, Tsuyoshi Ichikawa, Shinya Harada, Masahito Naito, Yukitoshi Sato, Masato Katagiri

J Thorac Dis· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma.
Yoshiro Nakahara, Tomoya Fukui, Masayuki Shirasawa, Shinya Harada, Seiichiro Kusuhara, Masato Katagiri

Intern Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.
Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara, Yasuhiro Hiyoshi, Mikiko Ishihara, Masato Katagiri

Cancer Manag Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective study.
Hideyuki Sone, Satoshi Igawa, Masashi Kasajima, Mikiko Ishihara, Yasuhiro Hiyoshi, Masato Katagiri

Thorac Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance status.
Satoshi Igawa, Masayuki Shirasawa, Takahiro Ozawa, Noriko Nishinarita, Yuriko Okuma, Masato Katagiri

Thorac Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis